US20190160210A1 - Vacuum Wound Device - Google Patents
Vacuum Wound Device Download PDFInfo
- Publication number
- US20190160210A1 US20190160210A1 US16/265,004 US201916265004A US2019160210A1 US 20190160210 A1 US20190160210 A1 US 20190160210A1 US 201916265004 A US201916265004 A US 201916265004A US 2019160210 A1 US2019160210 A1 US 2019160210A1
- Authority
- US
- United States
- Prior art keywords
- sponge
- vacuum
- wound
- tube
- tubing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000027418 Wounds and injury Diseases 0.000 claims description 74
- 206010052428 Wound Diseases 0.000 claims description 73
- 230000000153 supplemental effect Effects 0.000 claims description 23
- 230000007246 mechanism Effects 0.000 claims description 19
- 230000008878 coupling Effects 0.000 claims description 14
- 238000010168 coupling process Methods 0.000 claims description 14
- 238000005859 coupling reaction Methods 0.000 claims description 14
- 239000012530 fluid Substances 0.000 claims description 12
- 238000002560 therapeutic procedure Methods 0.000 claims description 12
- 238000004873 anchoring Methods 0.000 claims description 5
- 239000011148 porous material Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 22
- 239000000463 material Substances 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 9
- 230000008901 benefit Effects 0.000 description 6
- 230000007547 defect Effects 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 230000035876 healing Effects 0.000 description 5
- 230000002439 hemostatic effect Effects 0.000 description 5
- 238000013508 migration Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 238000012800 visualization Methods 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 208000005489 Esophageal Perforation Diseases 0.000 description 3
- 206010063560 Excessive granulation tissue Diseases 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000001804 debridement Methods 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 210000001126 granulation tissue Anatomy 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 2
- 108010048233 Procalcitonin Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002358 autolytic effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001839 endoscopy Methods 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000010388 wound contraction Effects 0.000 description 2
- 208000006017 Cardiac Tamponade Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical group CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030181 Oesophageal perforation Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 206010047363 Vesical fistula Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000007681 bariatric surgery Methods 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- -1 but not limited to Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012829 chemotherapy agent Substances 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000001559 fluids and secretion Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000005944 tissue migration Effects 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/916—Suction aspects of the dressing specially adapted for deep wounds
-
- A61M1/0086—
-
- A61F13/00042—
-
- A61F13/00068—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
- A61F13/01042—Absorbency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
-
- A61M1/0088—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/96—Suction control thereof
- A61M1/966—Suction control thereof having a pressure sensor on or near the dressing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/73—Suction drainage systems comprising sensors or indicators for physical values
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/92—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with liquid supply means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1042—Alimentary tract
- A61M2210/105—Oesophagus
Definitions
- the present invention relates to a system and method for vacuum wound therapy.
- Esophageal perforations are life-threatening conditions which experiences a 13.2% mortality rate.
- the process begins with an inflammatory response to a mediastinal contamination. Without effective drainage it can progress to sepsis and septic shock. Surgery is the typical treatment, but the high mortality rate often persists. Stents have been attempted, but these suffer from many disadvantages. Consequently, there is a need for device and method of closing and treating these perforations and other defects absent surgery.
- FIG. 1 is a top view of the components in one embodiment
- FIG. 2 is a perspective view of the sponge being coupled to the vacuum tubing via sutures in one embodiment
- FIG. 3 is a top perspective view of a sponge deployed in the human body
- FIG. 4A is a schematic of a delivery system with the sponge in the delivery position it one embodiment
- FIG. 4B is a schematic, of a delivery system with the sponge in the deployed position in one embodiment
- FIG. 5 is a top view of an embodiment utilizing a net
- FIG. 6 is a cross-sectional view of a vacuum tubing with an internal supplemental tube.
- Wound vacuum therapy has been utilized for closure of defects on surface areas.
- the application of such has been limited inside the body.
- the utilization of such a technique is hampered by the availability of devices to perform the technique.
- Wound closure relies upon the migration of epithelial and subcutaneous tissue to the wound. If, however, the wound is infected or too large, a zone of stasis forms and prevents the migration of this critical tissue, and consequently, prevents closure of the wound.
- Sutures or staples are often used to close wounds. Such mechanical tools offer tension on the tissue and generally result in increased tissue migration to help close the wound. However, sutures or staples often damage the tissue. Further, some wounds are so infected or inflamed, that closure via sutures or staples is impossible. Finally, utilizing sutures or staples requires surgery, which many patients are often too ill to survive.
- a wound vacuum device overcomes many of these problems associated with sutures or staples.
- a wound vacuum device is a device which can be used to treat wounds inside the body by applying a localized vacuum.
- a wound vacuum device removes excess fluid and bacterial, promotes blood flow to the desired tissue, and stimulates cells and cell growth.
- the wound vacuum device is connected to a vacuum pump which creates and delivers the vacuum.
- high vacuum suction with construction of an endoscopic sponge, vacuum tubing, and suture is utilized.
- Vacuum therapy is a cavity focused treatment method.
- the goal is to achieve complete closure of the cavity.
- Defect closure in one embodiment, is the byproduct of a successfully closed cavity.
- the placement can comprise either extraluminal placement, intraluminal placement, or combinations thereof. In one embodiment intraluminal placement is ideal for small cavities with little depth.
- FIG. 1 is a top view of the components in one embodiment.
- FIG. 1 shows the sponge 101 , which is utilized in the wound vacuum device.
- a sponge 101 is a porous device which delivers a vacuum within the body and provides a mechanism which heals internal wounds.
- the sponge 101 comprises a non-rigid and compressible material.
- a compressible material is a material whose outside diameter can be easily decreased with minimal force.
- a common household sponge for example, is a compressible material.
- metallic frames made from materials such as Nitinol, which comprise a memory material and a set shape, are compressible.
- the sponge 101 material can comprise foam, gauze, metallic structures, etc.
- the sponge 101 comprises a hydrophilic foam that induces granulation tissue.
- the sponge 101 comprises GranufoamTM manufactured by Kinetic Concepts Inc. of San Antonio, Tex.
- the sponge 101 comprises antibacterial, antibiotics, and/or antifungal properties.
- the sponge 101 comprises a hemostatic material.
- the sponge 101 comprises chemotherapy agents.
- the additional agents, such as the hemostatic material or the antibacterial can be coated, implanted, or otherwise incorporated into the sponge 101 . Further, the sponge 101 can be manufactured from these materials.
- the sponge 101 comprises a collagen, such as a natural collagen.
- a collagen such as smooth muscle, basement membrane, lamina basement from human, animal and synthetic sources, bio-engineered material, etc.
- the sponge 101 comprises a Cook Oasis wound matrix sold by Smith & Nephew PLC, London, United Kingdom.
- the sponge 101 comprises an autolytic debridement material.
- it can comprise an amorphous hydrogel which gently re-hydrates necrotic tissue, facilitating autolytic debridement while being able to loosen and absorb slough and exudate.
- the sponge 101 can comprise a silicone gel or a hydrocellular foam.
- the sponge 101 can comprise natural strengthening cellulose fibers or gelling cellulose ethyl sulphonate fibers.
- the sponge 101 comprises a material which is 20% natural strengthening cellulose fibers and 80% gelling ceullose ethyl sulphonate fibers.
- the sponge 101 comprises an acellular matrix.
- the sponge 101 can be coated or otherwise incorporate these materials, or the sponge can be manufactured from these materials.
- the sponge material can comprise a hydrophobic material. This material has applications in urology, for example.
- the sponge 101 can comprise a mixture of materials of the materials discussed herein.
- the sponge 101 can comprise a hydrophobic and/or a hydrophilic sponge 101 .
- the sponge 101 comprises a hemostatic material.
- the material can comprise any material which offers hemostatic properties.
- the hemostatic material comprises XStatTMmanufactured by RevMedx, Inc. of Wilsonville, Oreg.
- the vacuum from the vacuum tube 102 connects and couples the sponge 101 to the bleeding site and provides some pressure to maintain the sponge 101 attached to the bleeding site until hemostasis begins.
- the sponge 101 comprises an anchoring device or other anti-migration device which helps keep the sponge 101 in the desired location.
- An anchoring device is any device known in the art to keep an object, such as a stent, lodged in a specified location within a body. These include hooks, areas of increased surface area, stents, etc.
- the sponge 101 can be used in conjunction with a stent for closure and wound healing. The stent can offer anti-migration benefits
- the sponge 101 can comprise virtually any desired shape and size, depending upon the application.
- the sponge can range from about 1 ⁇ 4 of an inch to several inches in length.
- the sponge 101 comprises an oblong shape and is about 7 cm in length and about 2 cm wide.
- the shape of the sponge 101 will depend upon the application.
- the sponge 101 comprises a Y-shape.
- one upper tip of the “Y” is placed within the lumen of the GI tract, the other upper tip of the “Y” is placed into the perforation, and the suction port location on the section within the GI tract.
- the sponge 101 is used in the esophagus and measures 10 cm by 3 cm. IN one embodiment in the GI, the sponge is about 7 cm by about 2.5 cm. This description is provided only to illustrate the benefits of various shapes, and should not be deemed limiting.
- the sponge 101 is a porous material.
- the porosity allows the sponge 101 to spread the vacuum across the surface area of the sponge, decreasing the concentration of a vacuum at a single point.
- the porous sponge 101 also offers increased surface area upon which blood cells and other cells can adhere and coagulate, healing the wound. Further, the sponge 101 acts as a filter. Smaller objects and fluid are allowed to pass, being sucked in by the vacuum and removed through the vacuum tubing 102 .
- the porous nature of the sponge 101 allows lavage to dislodge it from the lumen of the body cavity. The porous nature of the sponge can be used for therapy with instillation of various medications discussed herein.
- the sponge 101 comprises two lobes 104 separated by a suture 103 .
- the shape of sponge 101 can be controlled by placement of the suture or other tube coupling device 103 .
- the vacuum tubing 102 can comprise any medical grade, hollow, tubing which can withstand a vacuum.
- the vacuum tubing 102 comprises a nasogastric (“NG”) tube.
- NG tube is a tube which is generally inserted through the mouth or nose and placed into the desired location, for example, the esophagus or the stomach.
- the vacuum tubing 102 can comprise any suitable material.
- the vacuum tubing 102 comprises plastic.
- the outer diameter of the tubing can vary according to the application.
- the vacuum tubing 102 comprises a gauge between about 6 and 30.
- the vacuum tubing 102 comprises a 16 gauge. In one embodiment a 10 french and 16 tubing for the connection is utilized.
- the vacuum tubing 102 has a first end 107 and a second end 106 .
- the first end 107 is coupled, either directly or indirectly, to the sponge 101
- the second end 106 is coupled, either directly or indirectly, to the vacuum pump 105 .
- the first end 107 is downstream from the second end 106 .
- upstream and downstream refer to relative locations with downstream being a point closer to the wound and upstream being a point closer to the vacuum pump 105 .
- the sponge 101 is downstream of the vacuum pump 105
- the vacuum pump 105 is upstream of the sponge 101 .
- the vacuum tubing 102 is directly coupled to a vacuum pump 105 .
- the vacuum tubing 102 is not directly coupled to a vacuum pump 105 .
- the vacuum tubing 102 comprises an NG tube
- the NG tube is further coupled at its upstream end to another tube, and that tube is couple to the vacuum pump 105 .
- the vacuum pump 105 reads incorrect pressures resulting in false alarms, such as false lost suction alarms.
- An intermediate tubing reduces these false alarms.
- the tube coupling device 103 is any device which couples the vacuum tubing 102 with the sponge 101 .
- the tube coupling device 103 can comprise sutures, wires, thread, clamps, magnets, etc.
- the tube coupling device 103 comprises a material that rotates and locks in place.
- the tube coupling device 103 can comprise virtually any material, including but not limited to, metal, plastic, rubber, etc.
- the tube coupling device 103 comprises sutures which are sewn through both the vacuum tubing 102 and the sponge 101 .
- FIG. 2 is a perspective view of the sponge 101 being coupled to the vacuum tubing 102 via sutures in one embodiment.
- the first end 107 of vacuum tubing 102 in one embodiment, is first placed within the sponge 101 .
- the tubing 102 simply pierces the sponge 101 and is placed approximately in the middle of the sponge 101 .
- the sponge 101 is physically coupled to the tubing 102 .
- sutures are used as the tubing coupling device 103 to couple the sponge 101 to the vacuum tubing 102 .
- sutures pierce the vacuum tubing 102 at least one time, and in some embodiments, two or more times.
- the sutures are sewn through the sponge 101 to physically couple the sponge 101 to the vacuum tubing 102 .
- the ends of the sutures are tied, cut, or otherwise secured.
- FIG. 1 depicts a vacuum pump 105 .
- a vacuum pump 105 refers to any device which can create and supply a vacuum.
- a vacuum is any pressure below atmospheric pressure. Virtually any negative pressure (vacuum) can be utilized with the wound vacuum device.
- the vacuum pump 105 is capable of achieving pressures of between about 0.01 to 0.99 atmospheres.
- a continuous high negative suction is utilized.
- the negative pressure in one embodiment, is maintained at between about 125 and about 175 mmHg.
- FIG. 3 is a top perspective view of a sponge deployed in the human body.
- the sponge 101 is deployed into the wound such that it is adjacent to tissue.
- the vacuum tube 102 is coupled to the sponge 101 as well as the vacuum pump 105 (not depicted).
- the vacuum tubing 102 is delivering a negative pressure to the wound.
- the negative pressure pulls adjacent tissue, such as epithelial and subcutaneous tissue, to the wound to help heal the wound. Further, the negative pressure pulls and removes bacterial and infectious materials, also aiding in the healing. Finally, the negative pressure promotes granulation tissue. Thus, the negative pressure aids in healing and closing of the wound.
- the sponge 101 and vacuum tubing 102 are left in place for as long as necessary to heal the wound.
- the sponges 101 are left in place where deployed for as little as less than a day to more than two weeks, depending upon the clinical situation.
- the sponges are changed every 3 to 7 days depending upon the clinical situation.
- changing the sponges every 3 to 4 days has been found to be the optimal time to promote healing.
- exposure to secretions and fluids can cause buildup of material on and inside of the sponge sometimes leading to a reduction in suction or clogging.
- the sponge is changed on an on-demand basis during the acute infectious period.
- procalcitonin (PCT) levels are drawn to provide an early indicator of responses.
- the sizes of subsequent replacement sponges 101 are modified to account for wound contraction. In some embodiments, as the wound begins to contract, successively smaller sponges 101 are used. This aids in closing the defect.
- Endoscopic placement of wound vacuum devices as constructed by hand are often difficult to use and potentially complicated by the need for luminal visualization with air insufflation, blind insertions, and size of luminal constraints.
- Disrupted viscera i.e. perforations or fistulas are subject to air leakage with luminal insufflation during endoscopy which can cause serious life threatening complications including air embolus and cardiac tamponade.
- the insertion of the sponge without compression requires blind insertion with either the endoscope or overtube which during placement can cause perforation, tears with bleeding or other mechanical complications.
- the utilization of the device with blind insertions is often dangerous and technically challenging. Further complications include to air leakage and mechanical complications. Consequently, the lack of a delivery system is a deterrent for its utilization.
- FIG. 4A is a schematic of a delivery system with the sponge in the delivery position in one embodiment.
- FIG. 4B is a schematic of a delivery system with the sponge in the deployed position in one embodiment.
- the delivery system compresses the sponge 101 within a catheter 108 .
- the catheter 108 can comprise any delivery tube which comprises a diameter greater than the diameter of the vacuum tubing 102 .
- the catheter 108 houses the compressed sponge 101 , the vacuum tube 102 , and the guide wire 109 .
- the sponge compression allows a smaller diameter catheter 108 to be positioned for deployment than if the sponge 101 were not compressed.
- the guide wire 109 can comprise any guide wire known in the art.
- the operator uses the guide wire 109 to control and direct the placement of the sponge 101 .
- the catheter 108 is withdrawn, and the sponge 101 is allowed to expand.
- FIG. 4B shows the expanded sponge 101 with the catheter 108 removed.
- the sponge 101 , vacuum tubes 102 , and/or the guide wire 109 comprise markers. Markers allow the operator to determine the location of the delivery system within the body. Those skilled in the art will understand the various markers that can be utilized.
- the guide wire 109 allows the operator to better control and deliver the sponge 101 compared to blind insertion.
- the use of a catheter 108 or other such sheath allows for a more compact delivery mechanism. This allows the sponge 108 to be utilized in smaller spaces and channels than using an uncompressed sponge.
- the sponge 101 expands upon removal of the catheter 108 , this is for illustrative purposes only and should not be deemed limiting.
- There are several release mechanisms including a covering sheath with exposure of the sponge by utilization of either a plunger device to expose the sponge or withdrawing the sheath over the sponge so that it would become free, or removal of a covering wrap.
- the sponge 101 is restricted by a string which is wound about the sponge 101 to constrain the sponge 101 . When the string is removed, the sponge 101 can expand.
- FIG. 5 is a top view of an embodiment utilizing a net.
- Another alternative for deployment and/or recapture includes a web-like net 111 that can be pulled like a draw string to capture the sponge 101 for delivery and released within the lumen.
- the net 111 can comprise virtually any medical grade material which encompasses the sponge 101 . When pulled, the net 11 pulls and directs the sponge 101 . If the net 111 , for example, is pulled within a catheter 108 , then the sponge 101 will compress within the catheter 108 . Likewise, if the catheter 108 is removed, the sponge 101 will assume the uncompressed state.
- the sponge 101 comprises an attaching mechanism 110 .
- the attaching mechanism 110 can be coupled to the sponge 101 directly, or the attaching mechanism 110 can be attached via the net 111 .
- An attaching mechanism 110 is a device which allows the sponge 101 to be attached to a delivery and/or removal system.
- the attaching mechanism 110 can comprise threading, snaps, or other mechanism features which allow the coupling of two objects.
- the guide wire 109 can be attached to the sponge 101 via the attaching mechanism 110 .
- the catheter 108 and/or the guide wire 109 can be removed while leaving the sponge 101 and the vacuum tubing 102 in place.
- the guide wire 109 can couple to the attaching mechanism 110 , and pull the sponge 101 to the compressed position within the catheter 108 .
- the delivery system can be placed over a wire or freely passed depending on the location of therapy intended.
- the vacuum tubing 102 can be routed per nasal or per other created ostomy depending on the location and nature of the malady. Further, in one embodiment, multiple small lumens within the tubing 102 would allow for sensing, monitoring, installation of medications, and optical viewing.
- the vacuum wound device there are several methods to deploy and remove the vacuum wound device. In one embodiment it is deployed without the use of endoscopy. In another embodiment the wound vacuum device is placed alongside the endoscope with a release mechanism. In still other embodiments the wound vacuum device 101 is placed through a working channel in the endoscope over a wire or freely into the wound. Other techniques include over the scope attachment, through the scope, guidewire stent scope withdrawn, an NG tube, and other deployment methods known in the art. In one embodiment a piggyback method is utilized whereby the suture is grabbed with forceps and directed to the desired location. In one such piggyback method, an additional suture forms a loop at one end of the sponge.
- the loop of the suture is grasped and guided with a device such as an endoscope.
- a device such as an endoscope.
- the tube is grabbed with forceps a few centimeters behind the sponge. This allows the sponge to flex backwards on itself.
- a rendezvous method is utilized.
- an open ended drain is accessible with an endoscopic or gastronomic tube.
- the sponge 101 is ready to be pulled into place.
- a suture placed at the end of the sponge 101 helps allow the sponge 101 to be pulled into the desired location.
- the sponge is placed via percutaneous insertion.
- FIG. 6 is a cross-sectional view of a vacuum tubing with an internal supplemental tube.
- a supplemental tube 112 is an additional tube which travels parallel with the vacuum tubing 102 which is used to deliver or remove a substance.
- the supplemental tube 112 can be located within the vacuum tubing 102 as illustrated, or the vacuum tubing 102 can be located within the supplemental tube 112 .
- the vacuum tubing 102 comprises one or more supplemental tubes 112 .
- the supplemental tube 112 fits within the vacuum tubing 102 .
- the supplemental tube 112 can be used to delivery substances such as a saline flush, chemotherapy drugs, medicinal fluids or gels, medicines, antibacterial agents, etc.
- the vacuum tubing 102 provides the suction and the supplemental tube 112 simultaneously provides the substance to the wound.
- the supplemental tube 112 can be used to supply fluids to wash and flush the wound.
- the same fluids or substance supplied by the supplemental tube 112 can then be removed and withdrawn by the vacuum tubing 102 .
- the fluid or substance being supplied by the supplemental tube 112 travels in the opposite direction from the fluid being withdrawn by the vacuum tubing 102 .
- the supplemental tube 112 can house sensing devices for bacterial, blood, optics, sensors, medications, etc.
- the wound vacuum device described herein can be used to close wounds located throughout the body.
- the wound vacuum device can be used to heal wounds located in in gastrointestinal tract (“GI tract”) and other organs.
- the wound vacuum device can be used for fistulas and perforation of the esophagus, stomach, and duodenum (small intestines), as well as colonic applications.
- the device is a remedy for bariatric surgery complications.
- the device is utilized on devastating injuries where the patients are too ill to survive surgery.
- the device is used in other maladies including bladder fistula and pancreas.
- the device us used in the abdomen, pelvis, chest, urology, gyn, and other orthopedic and drain applications.
- the wound vacuum device described herein can also function as a drain.
- a drain is used to remove fluids such as pus, blood, or other fluids, away from a surgical site.
- Use of the device as a drain is similar to the use described above.
- the sponge 101 acts as a filter which allows smaller objects and fluids to be withdrawn into the vacuum and removed via the vacuum tubing 102 . Because the sponge 101 , in one embodiment, acts as a filter, and due, in part, to the increased surface area, plugging of the sponge 101 is reduced compared to prior art drains. The sponge 101 prevents larger items, which could potentially clog or plug the vacuum tubing 102 , from reaching the vacuum tubing 102 .
- the open cell structure of the sponge 101 provides increased suction distribution over a larger surface area when compared to traditional draining methods and devices.
- the device and method discussed herein has a distinct advantage over traditional draining methods and devices in its ability to remove the septic focus.
- the sponge 101 can be used to function as a drain in virtually any circumstance where a drain would typically be utilized. These include, but are not limited to, GI, chest, abdomen, other such orthopedics, etc. When used as a drain, the sponge 101 can be delivered and recaptured using virtually any of the methods or devices discussed herein.
- the device can be used to close a variety of defects and perforations.
- One embodiment will now be discussed with regards to an esophageal perforation. This is for illustrative purposes only and should not be deemed limiting.
- the therapy was performed under general endotracheal anesthesia.
- other types of anesthesia including regional blocks and sedation can be used.
- no anesthesia is used.
- the cavity is assed to determine the size of the defect. Any structures with the cavity are identified, as are any problematic drainage areas which could not be drained with vacuum therapy alone.
- a CT scan can be used. The presence of necrosis is also checked.
- the cavity is irrigated, and debrided, if necessary, using methods and devices known in the art.
- a vacuum tube 102 such as an NG tube, is placed down through the nose and back out through the mouth. The sponge is then secured to the NG tube using methods and devices discussed herein.
- a tunnel within the sponge is created to provide space for the NG tube.
- This tunneling can be created by cutting or otherwise removing sponge in the area of the tunnel.
- the tunnel is created by forcing the NG tube through the sponge.
- all drain holes in the NG tube are covered by the sponge. This helps prevent direct suctioning of tissue. It further helps reduce blockage.
- a vacuum is applied to the NG tube prior to removing the endoscope.
- the goal of the vacuum therapy is to achieve complete closure of the cavity.
- complete closure refers to cavities which were 1 cm or less in depth, which illustrated good granulation tissue, and which appeared sealed on endoscopic examination. The complete closure is achieved through a combination of wound contraction, otherwise known as a cavity collapse, as well as granulations formation.
- the sponge can be removed by a variety of methods and devices.
- the sponge is removed by reversing the steps in which it was inserted.
- the sponge is removed via an endoscope.
- the sponge is first flushed with saline through the NG tube. Thereafter, either the NG tube or the suture is grabbed with forceps, such as rat tooth forceps, and is pulled out of the mouth.
- forceps such as rat tooth forceps
- the forceps were used to grab the NG tube 1-2 cm behind the sponge. This allows the sponge to retroflex backward allowing for better visualization.
- a sutured loop was attached to the end of the NG tube and grasped, and the sponge was guided down inline with the endoscope.
- a wound vacuum device comprising:
- wound vacuum device of any proceeding or preceding claim further comprising a net, wherein said net fully encompasses said sponge, and wherein said net further comprises an attaching mechanism.
- a system for use in wound vacuum therapy comprising:
- Clause 11 The system of claim 10 further comprising a guide wire.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- External Artificial Organs (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
- This application is a continuation of U.S. Ser. No. 14/695,755 filed Apr. 24, 2015, and claims priority to provisional application. 61/984,238 filed Apr. 25, 2014, the entirety of both of which are incorporated herein by reference.
- The present invention relates to a system and method for vacuum wound therapy.
- Esophageal perforations are life-threatening conditions which experiences a 13.2% mortality rate. The process begins with an inflammatory response to a mediastinal contamination. Without effective drainage it can progress to sepsis and septic shock. Surgery is the typical treatment, but the high mortality rate often persists. Stents have been attempted, but these suffer from many disadvantages. Consequently, there is a need for device and method of closing and treating these perforations and other defects absent surgery.
- The novel features believed characteristic of the invention are set forth in the appended claims. The invention itself, however, as well as a preferred mode of use, further objectives and advantages thereof, will be best understood by reference to the following detailed description of illustrative embodiments when read in conjunction with the accompanying drawings, wherein:
-
FIG. 1 is a top view of the components in one embodiment; -
FIG. 2 is a perspective view of the sponge being coupled to the vacuum tubing via sutures in one embodiment; -
FIG. 3 is a top perspective view of a sponge deployed in the human body; -
FIG. 4A is a schematic of a delivery system with the sponge in the delivery position it one embodiment; -
FIG. 4B is a schematic, of a delivery system with the sponge in the deployed position in one embodiment; -
FIG. 5 is a top view of an embodiment utilizing a net; -
FIG. 6 is a cross-sectional view of a vacuum tubing with an internal supplemental tube. - Several embodiments of Applicant's invention will now be described with reference to the drawings. Unless otherwise noted, like elements will be identified by identical numbers throughout all figures. The invention illustratively disclosed herein suitably may be practiced in the absence of any element which is not specifically disclosed herein.
- Wound vacuum therapy has been utilized for closure of defects on surface areas. The application of such has been limited inside the body. The utilization of such a technique is hampered by the availability of devices to perform the technique.
- Wound closure relies upon the migration of epithelial and subcutaneous tissue to the wound. If, however, the wound is infected or too large, a zone of stasis forms and prevents the migration of this critical tissue, and consequently, prevents closure of the wound. Sutures or staples are often used to close wounds. Such mechanical tools offer tension on the tissue and generally result in increased tissue migration to help close the wound. However, sutures or staples often damage the tissue. Further, some wounds are so infected or inflamed, that closure via sutures or staples is impossible. Finally, utilizing sutures or staples requires surgery, which many patients are often too ill to survive. A wound vacuum device overcomes many of these problems associated with sutures or staples.
- A wound vacuum device, as used herein, is a device which can be used to treat wounds inside the body by applying a localized vacuum. A wound vacuum device, in one embodiment, removes excess fluid and bacterial, promotes blood flow to the desired tissue, and stimulates cells and cell growth. The wound vacuum device is connected to a vacuum pump which creates and delivers the vacuum. In one embodiment, high vacuum suction with construction of an endoscopic sponge, vacuum tubing, and suture is utilized.
- Endoluminal vacuum therapy, utilizing a wound vacuum device, improves healing by removing infected secretions, reducing edema, increasing local perfusion, and promoting granulations tissue formulation. The results thus far demonstrate that this therapy has successfully closed esophageal perforations and leaks and done so while achieving low mortality rates. Vacuum therapy is a cavity focused treatment method. In one embodiment, the goal is to achieve complete closure of the cavity. Defect closure, in one embodiment, is the byproduct of a successfully closed cavity. In one embodiment, the placement can comprise either extraluminal placement, intraluminal placement, or combinations thereof. In one embodiment intraluminal placement is ideal for small cavities with little depth.
-
FIG. 1 is a top view of the components in one embodiment.FIG. 1 shows thesponge 101, which is utilized in the wound vacuum device. Asponge 101, as used herein, is a porous device which delivers a vacuum within the body and provides a mechanism which heals internal wounds. In one embodiment thesponge 101 comprises a non-rigid and compressible material. A compressible material is a material whose outside diameter can be easily decreased with minimal force. A common household sponge, for example, is a compressible material. Likewise, metallic frames made from materials such as Nitinol, which comprise a memory material and a set shape, are compressible. Thesponge 101 material can comprise foam, gauze, metallic structures, etc. In one embodiment thesponge 101 comprises a hydrophilic foam that induces granulation tissue. In one embodiment thesponge 101 comprises Granufoam™ manufactured by Kinetic Concepts Inc. of San Antonio, Tex. - In one embodiment the
sponge 101 comprises antibacterial, antibiotics, and/or antifungal properties. In another embodiment, thesponge 101 comprises a hemostatic material. In still other embodiments thesponge 101 comprises chemotherapy agents. The additional agents, such as the hemostatic material or the antibacterial can be coated, implanted, or otherwise incorporated into thesponge 101. Further, thesponge 101 can be manufactured from these materials. - In other embodiments the
sponge 101 comprises a collagen, such as a natural collagen. Examples of a collagen include smooth muscle, basement membrane, lamina propria from human, animal and synthetic sources, bio-engineered material, etc. In still other embodiments, thesponge 101 comprises a Cook Oasis wound matrix sold by Smith & Nephew PLC, London, United Kingdom. In still other embodiments thesponge 101 comprises an autolytic debridement material. For example, it can comprise an amorphous hydrogel which gently re-hydrates necrotic tissue, facilitating autolytic debridement while being able to loosen and absorb slough and exudate. Further, in some embodiments, thesponge 101 can comprise a silicone gel or a hydrocellular foam. Thesponge 101, in some embodiments, can comprise natural strengthening cellulose fibers or gelling cellulose ethyl sulphonate fibers. Specifically, in one embodiment thesponge 101 comprises a material which is 20% natural strengthening cellulose fibers and 80% gelling ceullose ethyl sulphonate fibers. In another embodiment thesponge 101 comprises an acellular matrix. As above, thesponge 101 can be coated or otherwise incorporate these materials, or the sponge can be manufactured from these materials. - In one embodiment the sponge material can comprise a hydrophobic material. This material has applications in urology, for example. In some embodiments the
sponge 101 can comprise a mixture of materials of the materials discussed herein. In other embodiments thesponge 101 can comprise a hydrophobic and/or ahydrophilic sponge 101. - As discussed, in one embodiment the
sponge 101 comprises a hemostatic material. The material can comprise any material which offers hemostatic properties. In one embodiment the hemostatic material comprises XStat™manufactured by RevMedx, Inc. of Wilsonville, Oreg. In operation, the vacuum from thevacuum tube 102 connects and couples thesponge 101 to the bleeding site and provides some pressure to maintain thesponge 101 attached to the bleeding site until hemostasis begins. - In one embodiment the
sponge 101 comprises an anchoring device or other anti-migration device which helps keep thesponge 101 in the desired location. An anchoring device is any device known in the art to keep an object, such as a stent, lodged in a specified location within a body. These include hooks, areas of increased surface area, stents, etc. Those skilled in the art will understand the various tools and mechanism which can be utilized on or with thesponge 101 to prevent migration of thesponge 101. Further, in one embodiment, thesponge 101 can be used in conjunction with a stent for closure and wound healing. The stent can offer anti-migration benefits - The
sponge 101 can comprise virtually any desired shape and size, depending upon the application. The sponge can range from about ¼ of an inch to several inches in length. In one embodiment thesponge 101 comprises an oblong shape and is about 7 cm in length and about 2 cm wide. The shape of thesponge 101 will depend upon the application. For example, in one embodiment thesponge 101 comprises a Y-shape. In one such embodiment one upper tip of the “Y” is placed within the lumen of the GI tract, the other upper tip of the “Y” is placed into the perforation, and the suction port location on the section within the GI tract. In one embodiment thesponge 101 is used in the esophagus and measures 10 cm by 3 cm. IN one embodiment in the GI, the sponge is about 7 cm by about 2.5 cm. This description is provided only to illustrate the benefits of various shapes, and should not be deemed limiting. - In one embodiment, and as depicted, the
sponge 101 is a porous material. The porosity allows thesponge 101 to spread the vacuum across the surface area of the sponge, decreasing the concentration of a vacuum at a single point. Theporous sponge 101 also offers increased surface area upon which blood cells and other cells can adhere and coagulate, healing the wound. Further, thesponge 101 acts as a filter. Smaller objects and fluid are allowed to pass, being sucked in by the vacuum and removed through thevacuum tubing 102. In one embodiment, the porous nature of thesponge 101 allows lavage to dislodge it from the lumen of the body cavity. The porous nature of the sponge can be used for therapy with instillation of various medications discussed herein. - As depicted, the
sponge 101 comprises twolobes 104 separated by asuture 103. As those skilled in the art will understand, the shape ofsponge 101 can be controlled by placement of the suture or othertube coupling device 103. - Returning back to
FIG. 1 , coupled to thesponge 101 is thevacuum tubing 102. Thevacuum tubing 102 can comprise any medical grade, hollow, tubing which can withstand a vacuum. In one embodiment, thevacuum tubing 102 comprises a nasogastric (“NG”) tube. An NG tube is a tube which is generally inserted through the mouth or nose and placed into the desired location, for example, the esophagus or the stomach. - The
vacuum tubing 102 can comprise any suitable material. In one embodiment, thevacuum tubing 102 comprises plastic. The outer diameter of the tubing can vary according to the application. In one embodiment thevacuum tubing 102 comprises a gauge between about 6 and 30. In one embodiment thevacuum tubing 102 comprises a 16 gauge. In one embodiment a 10 french and 16 tubing for the connection is utilized. - The
vacuum tubing 102 has afirst end 107 and asecond end 106. Thefirst end 107 is coupled, either directly or indirectly, to thesponge 101, and thesecond end 106 is coupled, either directly or indirectly, to thevacuum pump 105. In use thefirst end 107 is downstream from thesecond end 106. As used herein, upstream and downstream refer to relative locations with downstream being a point closer to the wound and upstream being a point closer to thevacuum pump 105. Thus, in operation thesponge 101 is downstream of thevacuum pump 105, and thevacuum pump 105 is upstream of thesponge 101. In one embodiment thevacuum tubing 102 is directly coupled to avacuum pump 105. In other embodiments, however, thevacuum tubing 102 is not directly coupled to avacuum pump 105. In one embodiment wherein thevacuum tubing 102 comprises an NG tube, the NG tube is further coupled at its upstream end to another tube, and that tube is couple to thevacuum pump 105. In some embodiments, wherein the NG tube is directly coupled to thevacuum pump 105, thevacuum pump 105 reads incorrect pressures resulting in false alarms, such as false lost suction alarms. An intermediate tubing, in some embodiments, reduces these false alarms. - Returning back to
FIG. 1 , coupling thesponge 101 to thevacuum tubing 102 is thetube coupling device 103. Thetube coupling device 103 is any device which couples thevacuum tubing 102 with thesponge 101. Thetube coupling device 103 can comprise sutures, wires, thread, clamps, magnets, etc. In one embodiment thetube coupling device 103 comprises a material that rotates and locks in place. Thetube coupling device 103 can comprise virtually any material, including but not limited to, metal, plastic, rubber, etc. In one embodiment, and as depicted, thetube coupling device 103 comprises sutures which are sewn through both thevacuum tubing 102 and thesponge 101. -
FIG. 2 is a perspective view of thesponge 101 being coupled to thevacuum tubing 102 via sutures in one embodiment. Thefirst end 107 ofvacuum tubing 102, in one embodiment, is first placed within thesponge 101. In one embodiment, thetubing 102 simply pierces thesponge 101 and is placed approximately in the middle of thesponge 101. Thereafter, thesponge 101 is physically coupled to thetubing 102. As depicted, sutures are used as thetubing coupling device 103 to couple thesponge 101 to thevacuum tubing 102. In one embodiment, sutures pierce thevacuum tubing 102 at least one time, and in some embodiments, two or more times. The sutures are sewn through thesponge 101 to physically couple thesponge 101 to thevacuum tubing 102. Thereafter, the ends of the sutures are tied, cut, or otherwise secured. - Returning back to
FIG. 1 ,FIG. 1 depicts avacuum pump 105. Avacuum pump 105, as used herein, refers to any device which can create and supply a vacuum. A vacuum is any pressure below atmospheric pressure. Virtually any negative pressure (vacuum) can be utilized with the wound vacuum device. In one embodiment thevacuum pump 105 is capable of achieving pressures of between about 0.01 to 0.99 atmospheres. In one embodiment a continuous high negative suction is utilized. The negative pressure, in one embodiment, is maintained at between about 125 and about 175 mmHg. -
FIG. 3 is a top perspective view of a sponge deployed in the human body. As can be seen, thesponge 101 is deployed into the wound such that it is adjacent to tissue. Thevacuum tube 102 is coupled to thesponge 101 as well as the vacuum pump 105 (not depicted). Thus, thevacuum tubing 102 is delivering a negative pressure to the wound. The negative pressure pulls adjacent tissue, such as epithelial and subcutaneous tissue, to the wound to help heal the wound. Further, the negative pressure pulls and removes bacterial and infectious materials, also aiding in the healing. Finally, the negative pressure promotes granulation tissue. Thus, the negative pressure aids in healing and closing of the wound. - The
sponge 101 andvacuum tubing 102 are left in place for as long as necessary to heal the wound. In some embodiments, thesponges 101 are left in place where deployed for as little as less than a day to more than two weeks, depending upon the clinical situation. In one embodiment the sponges are changed every 3 to 7 days depending upon the clinical situation. In one embodiment changing the sponges every 3 to 4 days has been found to be the optimal time to promote healing. In some embodiments, exposure to secretions and fluids can cause buildup of material on and inside of the sponge sometimes leading to a reduction in suction or clogging. In one embodiment the sponge is changed on an on-demand basis during the acute infectious period. To monitor when the sponge needs changing, in one embodiment procalcitonin (PCT) levels are drawn to provide an early indicator of responses. In one embodiment, the sizes ofsubsequent replacement sponges 101 are modified to account for wound contraction. In some embodiments, as the wound begins to contract, successivelysmaller sponges 101 are used. This aids in closing the defect. - Endoscopic placement of wound vacuum devices as constructed by hand are often difficult to use and potentially complicated by the need for luminal visualization with air insufflation, blind insertions, and size of luminal constraints. Disrupted viscera i.e. perforations or fistulas are subject to air leakage with luminal insufflation during endoscopy which can cause serious life threatening complications including air embolus and cardiac tamponade. The insertion of the sponge without compression requires blind insertion with either the endoscope or overtube which during placement can cause perforation, tears with bleeding or other mechanical complications. The utilization of the device with blind insertions is often dangerous and technically challenging. Further complications include to air leakage and mechanical complications. Consequently, the lack of a delivery system is a deterrent for its utilization.
-
FIG. 4A is a schematic of a delivery system with the sponge in the delivery position in one embodiment.FIG. 4B is a schematic of a delivery system with the sponge in the deployed position in one embodiment. Turning toFIG. 4A , in one embodiment the delivery system compresses thesponge 101 within acatheter 108. Thecatheter 108 can comprise any delivery tube which comprises a diameter greater than the diameter of thevacuum tubing 102. As depicted thecatheter 108 houses thecompressed sponge 101, thevacuum tube 102, and theguide wire 109. The sponge compression allows asmaller diameter catheter 108 to be positioned for deployment than if thesponge 101 were not compressed. - The
guide wire 109 can comprise any guide wire known in the art. The operator uses theguide wire 109 to control and direct the placement of thesponge 101. At the desired location, thecatheter 108 is withdrawn, and thesponge 101 is allowed to expand.FIG. 4B shows the expandedsponge 101 with thecatheter 108 removed. - In one embodiment the
sponge 101,vacuum tubes 102, and/or theguide wire 109 comprise markers. Markers allow the operator to determine the location of the delivery system within the body. Those skilled in the art will understand the various markers that can be utilized. - There are several benefits in using a system such as that depicted in
FIGS. 4A and 4B . First, theguide wire 109 allows the operator to better control and deliver thesponge 101 compared to blind insertion. Second, as noted above, the use of acatheter 108 or other such sheath allows for a more compact delivery mechanism. This allows thesponge 108 to be utilized in smaller spaces and channels than using an uncompressed sponge. - While one embodiment has been discussed wherein the
sponge 101 expands upon removal of thecatheter 108, this is for illustrative purposes only and should not be deemed limiting. There are several release mechanisms including a covering sheath with exposure of the sponge by utilization of either a plunger device to expose the sponge or withdrawing the sheath over the sponge so that it would become free, or removal of a covering wrap. For example, in one embodiment thesponge 101 is restricted by a string which is wound about thesponge 101 to constrain thesponge 101. When the string is removed, thesponge 101 can expand. -
FIG. 5 is a top view of an embodiment utilizing a net. Another alternative for deployment and/or recapture includes a web-like net 111 that can be pulled like a draw string to capture thesponge 101 for delivery and released within the lumen. The net 111 can comprise virtually any medical grade material which encompasses thesponge 101. When pulled, the net 11 pulls and directs thesponge 101. If the net 111, for example, is pulled within acatheter 108, then thesponge 101 will compress within thecatheter 108. Likewise, if thecatheter 108 is removed, thesponge 101 will assume the uncompressed state. - As depicted in
FIG. 5 , thesponge 101 comprises an attachingmechanism 110. The attachingmechanism 110 can be coupled to thesponge 101 directly, or the attachingmechanism 110 can be attached via the net 111. An attachingmechanism 110 is a device which allows thesponge 101 to be attached to a delivery and/or removal system. The attachingmechanism 110 can comprise threading, snaps, or other mechanism features which allow the coupling of two objects. As one, non-limiting example, consider the delivery system ofFIG. 4 utilizing acatheter 108 and aguide wire 109. In such an embodiment, once deployed, theguide wire 109 can be attached to thesponge 101 via the attachingmechanism 110. Accordingly, thecatheter 108 and/or theguide wire 109 can be removed while leaving thesponge 101 and thevacuum tubing 102 in place. Whene sponge 101 is to be removed, theguide wire 109, for example, can couple to the attachingmechanism 110, and pull thesponge 101 to the compressed position within thecatheter 108. - As noted, the delivery system can be placed over a wire or freely passed depending on the location of therapy intended. The
vacuum tubing 102 can be routed per nasal or per other created ostomy depending on the location and nature of the malady. Further, in one embodiment, multiple small lumens within thetubing 102 would allow for sensing, monitoring, installation of medications, and optical viewing. - As noted, there are several methods to deploy and remove the vacuum wound device. In one embodiment it is deployed without the use of endoscopy. In another embodiment the wound vacuum device is placed alongside the endoscope with a release mechanism. In still other embodiments the
wound vacuum device 101 is placed through a working channel in the endoscope over a wire or freely into the wound. Other techniques include over the scope attachment, through the scope, guidewire stent scope withdrawn, an NG tube, and other deployment methods known in the art. In one embodiment a piggyback method is utilized whereby the suture is grabbed with forceps and directed to the desired location. In one such piggyback method, an additional suture forms a loop at one end of the sponge. The loop of the suture is grasped and guided with a device such as an endoscope. In still another embodiment the tube is grabbed with forceps a few centimeters behind the sponge. This allows the sponge to flex backwards on itself. Such a method has an advantage in that it increases the visualization available to the user. In another embodiment a rendezvous method is utilized. In this method, an open ended drain is accessible with an endoscopic or gastronomic tube. First place the endoscopic forceps down, through, and out of the drain or gastronomic tube, under endoscopic visualization. Next, grab the forceps with another pair of endoscopic forceps placed through the scope. Next, interlock each jaw in the closed position. Once the forceps are secured, the scope can then be withdrawn through the mouth. Now, thesponge 101 is ready to be pulled into place. In one embodiment, a suture placed at the end of thesponge 101 helps allow thesponge 101 to be pulled into the desired location. In one embodiment the sponge is placed via percutaneous insertion. -
FIG. 6 is a cross-sectional view of a vacuum tubing with an internal supplemental tube. Asupplemental tube 112 is an additional tube which travels parallel with thevacuum tubing 102 which is used to deliver or remove a substance. Thesupplemental tube 112 can be located within thevacuum tubing 102 as illustrated, or thevacuum tubing 102 can be located within thesupplemental tube 112. Referring toFIG. 6 , in one embodiment, and as illustrated, thevacuum tubing 102 comprises one or moresupplemental tubes 112. As depicted, thesupplemental tube 112 fits within thevacuum tubing 102. Thesupplemental tube 112 can be used to delivery substances such as a saline flush, chemotherapy drugs, medicinal fluids or gels, medicines, antibacterial agents, etc. In operation, thevacuum tubing 102 provides the suction and thesupplemental tube 112 simultaneously provides the substance to the wound. Thus, thesupplemental tube 112 can be used to supply fluids to wash and flush the wound. In one embodiment, the same fluids or substance supplied by thesupplemental tube 112 can then be removed and withdrawn by thevacuum tubing 102. In one embodiment the fluid or substance being supplied by thesupplemental tube 112 travels in the opposite direction from the fluid being withdrawn by thevacuum tubing 102. In still other embodiments thesupplemental tube 112 can house sensing devices for bacterial, blood, optics, sensors, medications, etc. - The wound vacuum device described herein can be used to close wounds located throughout the body. The wound vacuum device can be used to heal wounds located in in gastrointestinal tract (“GI tract”) and other organs. For example, the wound vacuum device can be used for fistulas and perforation of the esophagus, stomach, and duodenum (small intestines), as well as colonic applications. In one embodiment the device is a remedy for bariatric surgery complications. In still another embodiment the device is utilized on devastating injuries where the patients are too ill to survive surgery. In still other embodiments the device is used in other maladies including bladder fistula and pancreas. In still other embodiments the device us used in the abdomen, pelvis, chest, urology, gyn, and other orthopedic and drain applications.
- The wound vacuum device described herein can also function as a drain. A drain is used to remove fluids such as pus, blood, or other fluids, away from a surgical site. Use of the device as a drain is similar to the use described above. The
sponge 101 acts as a filter which allows smaller objects and fluids to be withdrawn into the vacuum and removed via thevacuum tubing 102. Because thesponge 101, in one embodiment, acts as a filter, and due, in part, to the increased surface area, plugging of thesponge 101 is reduced compared to prior art drains. Thesponge 101 prevents larger items, which could potentially clog or plug thevacuum tubing 102, from reaching thevacuum tubing 102. Further, in one embodiment the open cell structure of thesponge 101 provides increased suction distribution over a larger surface area when compared to traditional draining methods and devices. By providing continuous effective draining, the device and method discussed herein has a distinct advantage over traditional draining methods and devices in its ability to remove the septic focus. - The
sponge 101 can be used to function as a drain in virtually any circumstance where a drain would typically be utilized. These include, but are not limited to, GI, chest, abdomen, other such orthopedics, etc. When used as a drain, thesponge 101 can be delivered and recaptured using virtually any of the methods or devices discussed herein. - As noted, the device can be used to close a variety of defects and perforations. One embodiment will now be discussed with regards to an esophageal perforation. This is for illustrative purposes only and should not be deemed limiting.
- In this embodiment the therapy was performed under general endotracheal anesthesia. In other embodiments other types of anesthesia, including regional blocks and sedation can be used. In still other embodiments, no anesthesia is used. First the cavity is assed to determine the size of the defect. Any structures with the cavity are identified, as are any problematic drainage areas which could not be drained with vacuum therapy alone. In some embodiments, a CT scan can be used. The presence of necrosis is also checked. Next, the cavity is irrigated, and debrided, if necessary, using methods and devices known in the art. Thereafter, a
vacuum tube 102, such as an NG tube, is placed down through the nose and back out through the mouth. The sponge is then secured to the NG tube using methods and devices discussed herein. In one embodiment, a tunnel within the sponge is created to provide space for the NG tube. This tunneling can be created by cutting or otherwise removing sponge in the area of the tunnel. In other embodiments the tunnel is created by forcing the NG tube through the sponge. In one embodiment, all drain holes in the NG tube are covered by the sponge. This helps prevent direct suctioning of tissue. It further helps reduce blockage. In one embodiment, to prevent the sponge from being dislodged once placed, a vacuum is applied to the NG tube prior to removing the endoscope. - Treatment with the sponge, in combination with irrigation, and debridement can result in immediate reduction in the inflammatory response. In one embodiment, the goal of the vacuum therapy is to achieve complete closure of the cavity. In one embodiment, complete closure refers to cavities which were 1 cm or less in depth, which illustrated good granulation tissue, and which appeared sealed on endoscopic examination. The complete closure is achieved through a combination of wound contraction, otherwise known as a cavity collapse, as well as granulations formation.
- The sponge can be removed by a variety of methods and devices. In one embodiment the sponge is removed by reversing the steps in which it was inserted. In one embodiment the sponge is removed via an endoscope. The sponge is first flushed with saline through the NG tube. Thereafter, either the NG tube or the suture is grabbed with forceps, such as rat tooth forceps, and is pulled out of the mouth. In one embodiment the forceps were used to grab the NG tube 1-2 cm behind the sponge. This allows the sponge to retroflex backward allowing for better visualization. In other embodiments a sutured loop was attached to the end of the NG tube and grasped, and the sponge was guided down inline with the endoscope.
- While the invention has been particularly shown and described with reference to a preferred embodiment, it will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention.
- The following clauses are offered as further description of the disclosed invention.
- Clause 1. A wound vacuum device comprising:
-
- a compressible sponge;
- vacuum tubing comprising a first end and a second end, wherein said first end is coupled to said sponge via a tube coupling device;
- wherein said first end of said vacuum tubing is fully encompassed by said sponge.
- Clause 2. The wound vacuum device of any proceeding or preceding claim wherein said second end of vacuum tubing is coupled to a vacuum pump.
-
Clause 3. The wound vacuum device of any proceeding or preceding claim wherein said sponge further comprises an anchoring device. - Clause 4. The wound vacuum device of any proceeding or preceding claim further comprising a net, wherein said net fully encompasses said sponge, and wherein said net further comprises an attaching mechanism.
- Clause 5. The wound vacuum device of any proceeding or preceding claim wherein said vacuum tubing comprises a supplemental tube.
- Clause 6. The wound vacuum device of any proceeding or preceding claim wherein said supplemental tube is located within said vacuum tubing.
- Clause 7. The wound vacuum device of any proceeding or preceding claim wherein said compressible sponge comprises a Y-shape.
- Clause 8. The wound vacuum device of any proceeding or preceding claim wherein said sponge comprises a porous material.
- Clause 9. The wound vacuum device of any proceeding or preceding claim wherein said sponge comprises an oblong shape.
- Clause 10. A system for use in wound vacuum therapy, said system comprising:
-
- a wound vacuum device comprising:
- a compressible sponge;
- vacuum tubing comprising a first end and a second end, wherein said first end is coupled to said sponge via a tube coupling device;
- wherein said first end of said vacuum tubing is fully encompassed by said sponge.
- a delivery tube, wherein the delivery tube is sized so as to house the wound vacuum device.
- a wound vacuum device comprising:
- Clause 11. The system of claim 10 further comprising a guide wire.
- Clause 12. The system of any proceeding or preceding claim further comprising an attaching mechanism which couples the wound vacuum device to the guide wire.
- Clause 13 The system of any proceeding or preceding claim wherein said wound vacuum device further comprises a net which fully encompasses said sponge.
- Clause 14. The system of any proceeding or preceding claim wherein said net further comprises an attaching mechanism.
- Clause 15. The system of any proceeding or preceding claim wherein said vacuum tubing comprises a supplemental tube located within said vacuum tubing.
- Clause 16. The system of any proceeding or preceding claim wherein said supplemental tube houses a sensing device.
- Clause 17. The system of any proceeding or preceding claim wherein a fluid is pumped toward said wound vacuum device through said supplemental tube.
- Clause 18. The system of any proceeding or preceding claim further comprising markers.
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/265,004 US20190160210A1 (en) | 2014-04-25 | 2019-02-01 | Vacuum Wound Device |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461984238P | 2014-04-25 | 2014-04-25 | |
US14/695,755 US10232097B2 (en) | 2014-04-25 | 2015-04-24 | Vacuum wound device |
US16/265,004 US20190160210A1 (en) | 2014-04-25 | 2019-02-01 | Vacuum Wound Device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/695,755 Continuation US10232097B2 (en) | 2014-04-25 | 2015-04-24 | Vacuum wound device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190160210A1 true US20190160210A1 (en) | 2019-05-30 |
Family
ID=54333309
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/695,755 Expired - Fee Related US10232097B2 (en) | 2014-04-25 | 2015-04-24 | Vacuum wound device |
US16/265,004 Abandoned US20190160210A1 (en) | 2014-04-25 | 2019-02-01 | Vacuum Wound Device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/695,755 Expired - Fee Related US10232097B2 (en) | 2014-04-25 | 2015-04-24 | Vacuum wound device |
Country Status (2)
Country | Link |
---|---|
US (2) | US10232097B2 (en) |
WO (1) | WO2015164801A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019040656A1 (en) | 2017-08-23 | 2019-02-28 | Cor Medical Ventures LLC | Post-operative surgical site wound treatment and method for device removal |
CN108211025B (en) * | 2018-03-09 | 2024-01-05 | 溧阳市人民医院 | Wound surface negative pressure flushing drainage device |
KR102127666B1 (en) * | 2018-11-08 | 2020-06-29 | 서울대학교병원 | Needle Supporting Structure And Intravenous Catheter Including the same |
KR20220145858A (en) | 2020-02-27 | 2022-10-31 | 보스톤 싸이엔티픽 싸이메드 인코포레이티드 | Medical treatment systems and related methods |
WO2021234518A1 (en) * | 2020-05-18 | 2021-11-25 | Boston Scientific Limited | Medical treatment device and related methods thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5374261A (en) * | 1990-07-24 | 1994-12-20 | Yoon; Inbae | Multifunctional devices for use in endoscopic surgical procedures and methods-therefor |
GB2359755A (en) | 2000-03-03 | 2001-09-05 | Mediplus Ltd | Apparatus for assisting wound healing |
CN100509079C (en) | 2002-11-07 | 2009-07-08 | 罗尔夫·魏登哈根 | Endoscopic wound care treatment system and method |
US7438714B2 (en) * | 2003-09-12 | 2008-10-21 | Boston Scientific Scimed, Inc. | Vacuum-based catheter stabilizer |
DE202004018245U1 (en) * | 2004-11-24 | 2005-07-07 | Riesinger, Birgit | Drainage device for treating wounds using reduced pressure has absorption body with layer(s) of textile section enriched with super-absorbents enclosed by liquid transmissive sleeve; absorbed wound secretions remain in absorption body |
CN102430158B (en) * | 2006-02-06 | 2014-09-10 | 凯希特许有限公司 | Systems and methods for improved connection to wound dressings in conjunction with reduced pressure wound treatment systems |
US8771243B2 (en) * | 2007-02-01 | 2014-07-08 | University Of Cincinnati | Wound treatment system |
DE102008061535A1 (en) | 2008-12-03 | 2010-06-10 | Aesculap Ag | Medical absorbent body, in particular for the removal of wound fluids from human and / or animal body cavities, and method for its production |
EP2482912B1 (en) * | 2009-09-30 | 2019-10-23 | Lohmann & Rauscher GmbH & Co. KG | Vacuum sponge drainage |
CN201643356U (en) | 2010-05-18 | 2010-11-24 | 朱新生 | Negative pressure drainage device |
US8993831B2 (en) * | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
-
2015
- 2015-04-24 WO PCT/US2015/027615 patent/WO2015164801A1/en active Application Filing
- 2015-04-24 US US14/695,755 patent/US10232097B2/en not_active Expired - Fee Related
-
2019
- 2019-02-01 US US16/265,004 patent/US20190160210A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US10232097B2 (en) | 2019-03-19 |
WO2015164801A1 (en) | 2015-10-29 |
US20150306287A1 (en) | 2015-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190160210A1 (en) | Vacuum Wound Device | |
US11872340B2 (en) | Endoluminal vacuum therapy device | |
US11793922B2 (en) | Vacuum treatment array and film for producing a vacuum treatment array | |
EP2683285B1 (en) | Vacuum system and endoscopy arrangement for endoscopic vacuum therapy | |
US10675391B2 (en) | Vacuum sponge drainage | |
US9215964B2 (en) | Vacuum system and endoscopy arrangement for endoscopic vacuum therapy | |
US11937777B2 (en) | Vacuum sponge drainage | |
EP3134143B1 (en) | Vacuum wound device | |
US20210068865A1 (en) | Apparatuses and methods for improving recovery from minimally invasive surgery | |
DE102011013743A1 (en) | Vacuum system for intraluminal, intracavitary, intracorporeal, endoscopic vacuum therapy for treating internal wounds, has vacuum pump unit, which is connected in liquid conducting manner with liquid collecting element | |
KR20220148222A (en) | Medical systems, devices and related methods | |
KR102490033B1 (en) | Medical devices for treating fistulas | |
US20230012427A1 (en) | Vacuum sponge drainage | |
Mykhaylichenko et al. | Complex endoscopic treatment of staple line failure in bariatric surgery | |
Rowe | 1.9 Peritoneal lavage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |